Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

C

COAG

Hemab Therapeutics Holdings Inc

41.18

Nov 02 • 3:59 PM ET -0.27 (-0.65%)

41.18

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Small NASD

Peers: QURE AGIO IRON RARE NVO KROS SNY AAPG BCRX ABCL

| Held by: XBI IWM VTI VXF IWO SCHA VTWO IWN FFSM TMSL

Scroll to Statements

Index	RUT
Market Cap	1.92B
Enterprise Value	1.47B
Income	-
Sales	-
Book/sh	9.73
Cash/sh	9.79
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	72
IPO	May 01, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	4.23
P/C	4.20
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	35.85
Current Ratio	35.85
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.47
EPS next Q	-0.50
EPS this Y	95.48%
EPS next Y	19.06%
EPS next 5Y	64.54%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	-9.22% -

Insider Own	38.27%
Insider Trans	19.93%
Inst Own	60.29%
Inst Trans	46.50%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	21.28%
SMA50	9.10%
SMA200	11.85%
Trades

Shs Outstand	46.71M
Shs Float	28.84M
Short Float	10.96%
Short Ratio	6.89
Short Interest	3.16M
52W High	55.42 -25.69%
52W Low	23.00 79.04%
Volatility	7.64% 7.98%
ATR (14)	2.70
RSI (14)	66.09
Beta	-
Rel Volume	0.75
Avg Volume	458.83K
Volume	343,889

Perf Week	14.33%
Perf Month	32.37%
Perf Quarter	-11.48%
Perf Half Y	62.51%
Perf YTD	52.52%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	61.71
Prev Close	41.45
Price	41.18
Change %	-0.65%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)